303 related articles for article (PubMed ID: 37909877)
21. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I; de Nijs K; Cao P; Bastani M; Munshi V; Ten Haaf K; Jeon J; Gazelle GS; Feuer EJ; de Koning HJ; Meza R; Kong CY; Han SS; Plevritis SK
JAMA Oncol; 2021 Dec; 7(12):1833-1842. PubMed ID: 34673885
[TBL] [Abstract][Full Text] [Related]
22. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.
Williams RM; Li T; Luta G; Wang MQ; Adams-Campbell L; Meza R; Tammemägi MC; Taylor KL
Cancer; 2022 May; 128(9):1812-1819. PubMed ID: 35201610
[TBL] [Abstract][Full Text] [Related]
23. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
[TBL] [Abstract][Full Text] [Related]
24. Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial.
Taylor KL; Hagerman CJ; Luta G; Bellini PG; Stanton C; Abrams DB; Kramer JA; Anderson E; Regis S; McKee A; McKee B; Niaura R; Harper H; Ramsaier M
Lung Cancer; 2017 Jun; 108():242-246. PubMed ID: 28216065
[TBL] [Abstract][Full Text] [Related]
25. Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.
Pillay J; Rahman S; Klarenbach S; Reynolds DL; Tessier LA; Thériault G; Persaud N; Finley C; Leighl N; McInnes MDF; Garritty C; Traversy G; Tan M; Hartling L
Syst Rev; 2024 Mar; 13(1):88. PubMed ID: 38493159
[TBL] [Abstract][Full Text] [Related]
26. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
Rivera MP; Katki HA; Tanner NT; Triplette M; Sakoda LC; Wiener RS; Cardarelli R; Carter-Harris L; Crothers K; Fathi JT; Ford ME; Smith R; Winn RA; Wisnivesky JP; Henderson LM; Aldrich MC
Am J Respir Crit Care Med; 2020 Oct; 202(7):e95-e112. PubMed ID: 33000953
[No Abstract] [Full Text] [Related]
27. Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"?
Nishi SPE; Lowenstein LM; Mendoza TR; Lopez Olivo MA; Crocker LC; Sepucha K; Niu J; Volk RJ
Chest; 2021 Jul; 160(1):330-340. PubMed ID: 33556362
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.
Ritzwoller DP; Meza R; Carroll NM; Blum-Barnett E; Burnett-Hartman AN; Greenlee RT; Honda SA; Neslund-Dudas C; Rendle KA; Vachani A
JAMA Netw Open; 2021 Oct; 4(10):e2128176. PubMed ID: 34636916
[TBL] [Abstract][Full Text] [Related]
29. Lung Cancer Screening.
Choi HK; Mazzone PJ
Med Clin North Am; 2022 Nov; 106(6):1041-1053. PubMed ID: 36280331
[TBL] [Abstract][Full Text] [Related]
30. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study.
Kanodra NM; Pope C; Halbert CH; Silvestri GA; Rice LJ; Tanner NT
Ann Am Thorac Soc; 2016 Nov; 13(11):1977-1982. PubMed ID: 27676369
[TBL] [Abstract][Full Text] [Related]
31. Patient-Provider Lung Cancer Screening Discussions: An Analysis of a National Survey.
Nourmohammadi N; Liang THP; Sadigh G
Clin Lung Cancer; 2024 Jun; 25(4):e189-e195.e2. PubMed ID: 38522980
[TBL] [Abstract][Full Text] [Related]
32. A protocol for a cluster randomized trial of care delivery models to improve the quality of smoking cessation and shared decision making for lung cancer screening.
Lowenstein LM; Shih YT; Minnix J; Lopez-Olivo MA; Maki KG; Kypriotakis G; Leal VB; Shete SS; Fox J; Nishi SP; Cinciripini PM; Volk RJ
Contemp Clin Trials; 2023 May; 128():107141. PubMed ID: 36878389
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer screening provider recommendation and completion in black and White patients with a smoking history in two healthcare systems: a survey study.
Japuntich SJ; Walaska K; Friedman EY; Balletto B; Cameron S; Tanzer JR; Fang P; Clark MA; Carey MP; Fava J; Busch AM; Breault C; Rosen R
BMC Prim Care; 2024 Jun; 25(1):202. PubMed ID: 38849725
[TBL] [Abstract][Full Text] [Related]
34. Implementation of Lung Cancer Screening in the Veterans Health Administration.
Kinsinger LS; Anderson C; Kim J; Larson M; Chan SH; King HA; Rice KL; Slatore CG; Tanner NT; Pittman K; Monte RJ; McNeil RB; Grubber JM; Kelley MJ; Provenzale D; Datta SK; Sperber NS; Barnes LK; Abbott DH; Sims KJ; Whitley RL; Wu RR; Jackson GL
JAMA Intern Med; 2017 Mar; 177(3):399-406. PubMed ID: 28135352
[TBL] [Abstract][Full Text] [Related]
35. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
[TBL] [Abstract][Full Text] [Related]
36. Smoking cessation and shared decision-making practices about lung cancer screening among primary care providers.
Lopez-Olivo MA; Minnix JA; Fox JG; Nishi SPE; Lowenstein LM; Maki KG; Leal VB; Tina Shih YC; Cinciripini PM; Volk RJ
Cancer Med; 2021 Feb; 10(4):1357-1365. PubMed ID: 33463091
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
38. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium.
Rendle KA; Burnett-Hartman AN; Neslund-Dudas C; Greenlee RT; Honda S; Elston Lafata J; Marcus PM; Cooley ME; Vachani A; Meza R; Oshiro C; Simoff MJ; Schnall MD; Beaber EF; Doria-Rose VP; Doubeni CA; Ritzwoller DP
Cancer Prev Res (Phila); 2020 Feb; 13(2):129-136. PubMed ID: 31871221
[TBL] [Abstract][Full Text] [Related]
39. Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.
Fucito LM; Czabafy S; Hendricks PS; Kotsen C; Richardson D; Toll BA;
Cancer; 2016 Apr; 122(8):1150-9. PubMed ID: 26916412
[TBL] [Abstract][Full Text] [Related]
40. Impact of low-dose computed tomography screening on lung cancer incidence and outcomes.
Vachani A; Caruso C
Curr Opin Pulm Med; 2023 Jul; 29(4):232-238. PubMed ID: 37191171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
